Finance

Lists
Why is BIOA down ७.१०%?
Dive Deeper
BIOA:NASDAQ
BIOAGE Labs Inc
US$ ५.८९
-७.१०%
(-०.४५) 1D
अक्टोबर १२, १२:०१:०७ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BIOA...
Open
US$ ६.२४
High
US$ ६.३०
Low
US$ ५.८८
Mkt. cap
२७.०३ करोड
Avg. vol.
७.९१ लाख
Volume
१.६५ लाख
52-wk high
US$ २५.९६
52-wk low
US$ ५.०५
EPS
-US$ २.३९
Shares outstanding
४.५९ करोड
No. of employees
६१
Open
US$ ६.२४
High
US$ ६.३०
Low
US$ ५.८८
Mkt. cap
२७.०३ करोड
Avg. vol.
७.९१ लाख
Volume
१.६५ लाख
52-wk high
US$ २५.९६
52-wk low
US$ ५.०५
EPS
-US$ २.३९
Shares outstanding
४.५९ करोड
No. of employees
६१
News stories
From web sources and news partners
Investing.com
Investing.com
·
८ घण्टा पहिले
UBS initiates BioAge Labs stock coverage at neutral on DME focus
About BIOAGE Labs Inc
CEO-
Employees६१
Founded२०१५
HeadquartersEmeryville, क्यालिफोर्निया, संयुक्त राज्य अमेरिका
Sector-
Analyst ratings
Based on 10 analysts giving stock ratings to BIOA in the past 3 months
Buy
Buy
7
Hold
3
Sell
0
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for BIOA in the last 3 months.
Highest
Current US$ ५.८९
US$ ७३.०० (+१,१३९.३९%)
Average
US$ ३२.५६ (+४५२.८०%)
Lowest
US$ ८.०० (+३५.८२%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
UBS
Hold
Initiated
US$ ८.००
+३५.८%
10/11/2026
Alice Nettleton
UBS
Hold
Initiated
US$ ८.००
+३५.८%
10/12/2026
Samantha Semenkow
Citi
Buy
Maintained
US$ २१.००
+२५६.५%
09/28/2026
Joseph Stringer
Needham
Buy
Maintained
US$ ३५.००
+४९४.२%
09/14/2026
Adam Walsh
Roth MKM
Buy
Reiterated
US$ २५.००
+३२४.४%
09/09/2026
Michael Ulz
Morgan Stanley
Hold
Maintained
US$ २०.००
+२३९.६%
08/07/2026
Jay Olson
Oppenheimer
Buy
Maintained
US$ ५०.००
+७४८.९%
08/06/2026
Andy Hsieh
William Blair
Hold
Reiterated
-
-
08/06/2026
Yasmeen Rahimi
Piper Sandler
Buy
Reiterated
US$ ७३.००
+१,१३९.४%
08/06/2026
Thomas Shrader
BTIG
Buy
Maintained
US$ ४०.००
+५७९.१%
08/05/2026
Roger Song
Jefferies
Buy
Maintained
US$ २१.००
+२५६.५%
07/31/2026
Last report
२०२६ अगस्ट ५
Fiscal period
Q2 2026
-US$ ०.५८ / -US$ ०.६२
+७.०९%beat
Revenue / Est. (USD)
२४.५१ लाख / १४.९८ लाख
+६३.६५%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
२०.५४ लाख
३०.७८ लाख
२७.७२ लाख
२४.५१ लाख
Cost of goods sold
१.८५ करोड
२.४५ करोड
२.०४ करोड
२.४४ करोड
Cost of revenue
१.८५ करोड
२.४५ करोड
२.०४ करोड
२.४४ करोड
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
६६.८१ लाख
७०.०१ लाख
७७.३७ लाख
७४.१९ लाख
Operating expense
६६.८१ लाख
७०.०१ लाख
७७.३७ लाख
७४.१९ लाख
Total operating expenses
२.५२ करोड
३.१५ करोड
२.८१ करोड
३.१८ करोड
Operating income
-२.३१ करोड
-२.८४ करोड
-२.५४ करोड
-२.९३ करोड
Other non operating income
-४२.०० हजार
-२.२० लाख
-१.०७ लाख
-२.०१ लाख
EBT including unusual items
-२.०२ करोड
-२.५९ करोड
-२.२३ करोड
-२.६१ करोड
EBT excluding unusual items
-२.०२ करोड
-२.५९ करोड
-२.२३ करोड
-२.६१ करोड
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-२.०२ करोड
-२.५९ करोड
-२.२३ करोड
-२.६१ करोड
Net profit margin
-९८२.०३%
-८४२.८५%
-८०२.७८%
-१,०६४.७५%
Earnings per share
-०.५६
-०.७२
-०.५२
-०.५८
Interest and investment income
३१.६० लाख
२७.९२ लाख
३२.६८ लाख
३४.३८ लाख
Interest expense
-१.४९ लाख
-९२.०० हजार
-३९.०० हजार
-१.०० हजार
Net interest expenses
३०.११ लाख
२७.०० लाख
३२.२९ लाख
३४.३७ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-२.३१ करोड
-२.८४ करोड
-२.५३ करोड
-२.९३ करोड
Gain or loss from assets sale
-
२३.०० हजार
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू